Roche Holding AG (RHHBY)
OTCMKTS
· Delayed Price · Currency is USD
39.52
-0.23 (-0.58%)
Apr 25, 2025, 3:59 PM EDT
Roche Holding AG Revenue
In the year 2024, Roche Holding AG had annual revenue of 62.40B CHF with 3.23% growth. Roche Holding AG had revenue of 31.64B in the half year ending December 31, 2024, a decrease of -0.86%.
Revenue
62.40B CHF
Revenue Growth
+3.23%
P/S Ratio
3.68
Revenue / Employee
604.32K CHF
Employees
103,249
Market Cap
253.38B USD
Revenue Chart
* This company reports financials in CHF.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 62.40B | 1.95B | 3.23% |
Dec 31, 2023 | 60.44B | -5.37B | -8.16% |
Dec 31, 2022 | 65.81B | -36.00M | -0.05% |
Dec 31, 2021 | 65.85B | 5.51B | 9.13% |
Dec 31, 2020 | 60.34B | -3.41B | -5.35% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Northwest Biotherapeutics | 1.38M |
Elite Pharmaceuticals | 70.00M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics | 43.26M |
Roche Holding AG News
- 13 hours ago - 'Roche could've earned over 100 times what it cost for rare disease drug' - The Times of India
- 16 hours ago - Notable healthcare headlines for the week: Merck, Roche and Bausch Health in focus - Seeking Alpha
- 1 day ago - Zealand Pharma says obesity drug deal with Roche will help it stay independent - Financial Times
- 2 days ago - Roche: Key Products Stall, Obesity Pipeline Takes Shape - Seeking Alpha
- 3 days ago - New England Journal of Medicine publishes phase III data showing single-dose Xofluza significantly reduces influenza virus transmission - GlobeNewsWire
- 3 days ago - New England Journal of Medicine Publishes Phase III Data Showing Single-dose Xofluza Significantly Reduces Influenza Virus Transmission - Business Wire
- 3 days ago - Roche Holding AG (RHHBY) Q1 2025 Sales/ Trading Statement Call Transcript - Seeking Alpha
- 3 days ago - Pharma Giant Roche Tops First-Quarter Views; Sanofi's Sales Come In Mixed - Investor's Business Daily